HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical and ultrasonographic criteria for using ventriculoperitoneal shunts in newborns with myelomeningocele.

Abstract
Objective Hydrocephalus is one of the main complications associated with myelomeningocele (MM). This study aimed to identify clinical and ultrasonographic criteria for using ventriculoperitoneal (VP) shunts in this group of patients.Method A retrospective cohort study, based on established protocol for VP shunt implant in hydrocephalic children with MM. Parameters used to guide the indication of VP shunts included measurement of head circumference (HC), evaluation of fontanels, and measurement of lateral ventricular atrium (LVA) width by transcranial ultrasonography.Results 43 children were included in the analysis, of which 74% had hydrocephalus and required a VP shunt. These children had LVA width ≥ 15 mm, showed increased HC, or had bulging fontanels.Conclusion VP shunt is required in children with increased HC (≥ 2 standard deviation regarding age group), bulging fontanels, or LVA width of ≥ 15 mm after the closure of MM.
AuthorsJose Roberto Tude Melo, Pollyana Pacheco, Emília Nunes de Melo, Ângela Vasconcellos, Rosane Klein Passos
JournalArquivos de neuro-psiquiatria (Arq Neuropsiquiatr) Vol. 73 Issue 9 Pg. 759-63 (Sep 2015) ISSN: 1678-4227 [Electronic] Germany
PMID26352494 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Brazil (epidemiology)
  • Cohort Studies
  • Female
  • Humans
  • Hydrocephalus (diagnostic imaging, etiology, surgery)
  • Infant, Low Birth Weight
  • Infant, Newborn
  • Infant, Premature
  • Male
  • Meningomyelocele (complications)
  • Retrospective Studies
  • Sensitivity and Specificity
  • Ultrasonography
  • Ventriculoperitoneal Shunt

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: